Scinai Immunotherapeutics Ltd (SCNI)

Scinai Immunotherapeutics Ltd (SCNI) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $826,686; returns 1 day -7.6%, 1 week -25.0%, 1 year -96.0%.

Scinai Immunotherapeutics Ltd. (SCNI) is a biopharmaceutical company operating with two business units: a research and development division focused on inflammation and immunology (I&I) biological therapeutic products, and a boutique CDMO (Contract Development and Manufacturing Organization), Scinai Bioservices, that provides services to biotech companies.

Groups SCNI belongs to

• Biotechnology
• Recent Reverse Splits
• Israel Companies
• Biopharmaceutical
• Healthcare
• Life Sciences
• Contract Development and Manufacturing Organizations (CDMO)
• Antibody Therapeutics
• Clinical Stage Biotech
• Immunotherapy
• Biologics

SCNI financial model: income statement, cash flow and balance sheet